This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
After ISRG Q1 Earnings, 3 Medical Instrument Stocks Looking Up
by Zacks Equity Research
While the Medical Instrument industry has been oscillating between hope and despair, let us take a look at three stocks which are expected to put up an impressive show this earnings season like Intuitive Surgical.
Masimo (MASI) Launches Root Platform with Kite Trademark
by Zacks Equity Research
Irvine, CA-based Masimo Corporation (MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system).
Obamacare Holds Ground: 3 Medical Device Stocks to Gain
by Zacks Equity Research
Republican leaders have failed to play their "Trump card" this time, courtesy of the pullback of the Republican healthcare bill, the American Health Care Act (ACHA), which was designed to repeal the Affordable Care Act (ACA) or Obamacare.
Masimo (MASI) Up 20.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Medical Device Stocks to Brave Policy Uncertainty
by Zacks Equity Research
We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.
Can The Uptrend Continue for Masimo (MASI)?
by Zacks Equity Research
Investors certainly have to be happy with Masimo Corporation (MASI) and its short term performance
Masimo Announces Availability of RD SedLine Brain Sensors
by Zacks Equity Research
Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.
Is Masimo (MASI) a Great Growth Stock?
by Zacks Equity Research
One company that might be well-positioned for future earnings growth is Masimo Corporation (MASI).
Hit ETFs & Stocks from the Top Sector of February
by Sweta Killa
Inside the best performing sector of February and their best ETFs & stocks.
Cooper (COO) to Report Q1 Earnings: Is a Surprise in Store?
by Zacks Equity Research
The Cooper Companies Inc. (COO) is set to report first-quarter fiscal 2017 results after the market closes on Mar 2.
Follow Driehaus & Pick these 5 Best-Rated Momentum Stocks
by Zacks Equity Research
Investors with high risk appetite may think of using the Driehaus strategy to boost their portfolio returns.
DexCom (DXCM) Q4 Earnings: What to Expect from the Stock?
by Zacks Equity Research
DexCom, Inc. (DXCM) is set to report fiscal fourth-quarter 2017 results on Feb 28.
Can Penumbra (PEN) Spring a Surprise this Earnings Season?
by Zacks Equity Research
Penumbra Inc. (PEN) is slated to release fourth-quarter 2016 results on Feb 28, after market close.
Patterson Companies (PDCO) Q3 Earnings: What's in Store?
by Zacks Equity Research
Patterson Companies Inc. (PDCO) is set to report fiscal third-quarter 2017 results on Feb 23, before the opening bell.
Medtronic (MDT) Q3 Earnings: Disappointment in the Cards?
by Zacks Equity Research
Ireland-based medical device major Medtronic plc (MDT) is slated to report its third-quarter fiscal 2017 earnings on Feb 21, before the opening bell.
Masimo Gets CE Mark for RRp on MightySat Rx Pulse Oximeter
by Zacks Equity Research
Masimo Corporation (MASI) recently announced the receipt of CE mark approval for respiration rate measurement (RRp) on MightySat Rx fingertip pulse oximeter.
Masimo to Launch Advanced Monitoring Technologies in India
by Zacks Equity Research
Masimo (MASI) announced that it will launch Advanced Monitoring Technologies in the Indian market.
Masimo's (MASI) TFA-1 Forehead Sensor Gets FDA Approval
by Zacks Equity Research
Masimo Corporation (MASI) recently announced that its TFA-1 Single-Patient-Use Adhesive Forehead Sensor has received a 5I0(k) clearance from the U.S. FDA.
Masimo (MASI) Hits 52-Week High on Solid Growth Prospects
by Zacks Equity Research
Share price of Irvine, CA-based Masimo Corporation (MASI) reached a new 52-week high of $63.45 on Dec 7, finally closing a tad lower at $62.17.